AngioDynamics, Inc. (NASDAQ:ANGO) reported a narrower-than-expected Q1 fiscal 2026 loss per share of $0.10, beating the Zacks Consensus Estimate.The company's revenue reached $75.71 million, marking a 12.2% year-over-year increase, driven by significant growth in its Med Tech segment.AngioDynamics raised its fiscal year 2026 sales outlook to $308 million to $313 million, reflecting confidence in continued growth.AngioDynamics, Inc. (NASDAQ:ANGO), a prominent figure in the medical technology industry, focuse ...

ALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced the appointment of Raymond W. Cohen to its Board of Directors. “We are thrilled to welcome Raymond W. Cohen to the RxSight Board of Directors,” said J. Andy Corley, Chairman of the Board at RxSight. “Ray’s extensive track record in leading and scaling medical technology compani ...